Literature DB >> 8354987

Survival analysis of 118 patients with systemic sclerosis.

L Czirják1, Z Nagy, G Szegedi.   

Abstract

Life-table analysis based on the survival statistics of 118 Hungarian patients with systemic sclerosis suggests that the presence of skin hypo- and/or hyperpigmentation indicates a poor prognosis. Furthermore, truncal skin involvement, lung, cardiac, and renal manifestations, older age at the onset of disease, anaemia, hand deformity, and elevated erythrocyte sedimentation rate values, predict an unfavourable prognosis, whilst patients with exposure to chemicals shows a relatively favourable disease outcome.

Entities:  

Mesh:

Year:  1993        PMID: 8354987     DOI: 10.1111/j.1365-2796.1993.tb00753.x

Source DB:  PubMed          Journal:  J Intern Med        ISSN: 0954-6820            Impact factor:   8.989


  8 in total

1.  Predictors of survival in 171 patients with systemic sclerosis (scleroderma).

Authors:  Z Nagy; L Czirják
Journal:  Clin Rheumatol       Date:  1997-09       Impact factor: 2.980

2.  Spontaneous pneumothorax in a patient with systemic sclerosis.

Authors:  M Zeuner; U Müller-Ladner; V D Mohr; B Lang
Journal:  Clin Rheumatol       Date:  1996-03       Impact factor: 2.980

3.  Exposure to chemicals and systemic sclerosis.

Authors:  L Czirják; Z Csiki; Z Nagy; E Tóth
Journal:  Ann Rheum Dis       Date:  1995-06       Impact factor: 19.103

4.  Mortality and causes of death in a Swedish series of systemic sclerosis patients.

Authors:  R Hesselstrand; A Scheja; A Akesson
Journal:  Ann Rheum Dis       Date:  1998-11       Impact factor: 19.103

5.  High resolution computed tomography for the evaluation of lung involvement in 101 patients with scleroderma.

Authors:  K Dévényi; L Czirják
Journal:  Clin Rheumatol       Date:  1995-11       Impact factor: 2.980

6.  Left ventricular wall motion abnormalities in 80 patients with systemic sclerosis.

Authors:  I Hegedüs; L Czirják
Journal:  Clin Rheumatol       Date:  1995-03       Impact factor: 2.980

7.  Myocardial gallium-67 citrate scintigraphy in patients with systemic sclerosis.

Authors:  J Gaál; I Hegedüs; K Dévényi; L Czirják
Journal:  Ann Rheum Dis       Date:  1995-10       Impact factor: 19.103

8.  Rosuvastatin improves impaired endothelial function, lowers high sensitivity CRP, complement and immuncomplex production in patients with systemic sclerosis--a prospective case-series study.

Authors:  Orsolya Timár; Zoltán Szekanecz; György Kerekes; Judit Végh; Anna V Oláh; Gábor Nagy; Zoltán Csiki; Katalin Dankó; Szilvia Szamosi; Ágnes Németh; Pál Soltész; Gabriella Szücs
Journal:  Arthritis Res Ther       Date:  2013       Impact factor: 5.156

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.